COVID-19 Impact on Global Dry Eye Syndrome Drugs Market Size, Status and Forecast 2020-2026

September 2020 | 90 pages | ID: C6261E30831AEN
QYResearch

Abstracts

This report focuses on the global Dry Eye Syndrome Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dry Eye Syndrome Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Allergan
• Novartis
• Santen
• Takeda
• Otsuka
• Eyegate Pharma
• Can-Fite BioPharma
• Bausch and Lomb
• Auven Therapeutics (Celtic)
• Bridge Pharma
• Cellzome

Market segment by Type, the product can be split into

• Antibiotic Drops
• Hormone Drops
• Artificial Tears

Market segment by Application, split into

• Hospitals
• Clinics
• Household Use

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Dry Eye Syndrome Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Dry Eye Syndrome Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Dry Eye Syndrome Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dry Eye Syndrome Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antibiotic Drops
  1.4.3 Hormone Drops
  1.4.4 Artificial Tears
1.5 Market by Application
  1.5.1 Global Dry Eye Syndrome Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Household Use
1.6 Coronavirus Disease 2019 (Covid-19): Dry Eye Syndrome Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Dry Eye Syndrome Drugs Industry
    1.6.1.1 Dry Eye Syndrome Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Dry Eye Syndrome Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Dry Eye Syndrome Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Dry Eye Syndrome Drugs Market Perspective (2015-2026)
2.2 Dry Eye Syndrome Drugs Growth Trends by Regions
  2.2.1 Dry Eye Syndrome Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Dry Eye Syndrome Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Dry Eye Syndrome Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Dry Eye Syndrome Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Dry Eye Syndrome Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Dry Eye Syndrome Drugs Players by Market Size
  3.1.1 Global Top Dry Eye Syndrome Drugs Players by Revenue (2015-2020)
  3.1.2 Global Dry Eye Syndrome Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Dry Eye Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dry Eye Syndrome Drugs Market Concentration Ratio
  3.2.1 Global Dry Eye Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Dry Eye Syndrome Drugs Revenue in 2019
3.3 Dry Eye Syndrome Drugs Key Players Head office and Area Served
3.4 Key Players Dry Eye Syndrome Drugs Product Solution and Service
3.5 Date of Enter into Dry Eye Syndrome Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Dry Eye Syndrome Drugs Historic Market Size by Type (2015-2020)
4.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2021-2026)

5 DRY EYE SYNDROME DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Dry Eye Syndrome Drugs Market Size by Application (2015-2020)
5.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Dry Eye Syndrome Drugs Market Size (2015-2020)
6.2 Dry Eye Syndrome Drugs Key Players in North America (2019-2020)
6.3 North America Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
6.4 North America Dry Eye Syndrome Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Dry Eye Syndrome Drugs Market Size (2015-2020)
7.2 Dry Eye Syndrome Drugs Key Players in Europe (2019-2020)
7.3 Europe Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
7.4 Europe Dry Eye Syndrome Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Dry Eye Syndrome Drugs Market Size (2015-2020)
8.2 Dry Eye Syndrome Drugs Key Players in China (2019-2020)
8.3 China Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
8.4 China Dry Eye Syndrome Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Dry Eye Syndrome Drugs Market Size (2015-2020)
9.2 Dry Eye Syndrome Drugs Key Players in Japan (2019-2020)
9.3 Japan Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
9.4 Japan Dry Eye Syndrome Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Dry Eye Syndrome Drugs Market Size (2015-2020)
10.2 Dry Eye Syndrome Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Dry Eye Syndrome Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Dry Eye Syndrome Drugs Market Size (2015-2020)
11.2 Dry Eye Syndrome Drugs Key Players in India (2019-2020)
11.3 India Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
11.4 India Dry Eye Syndrome Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Dry Eye Syndrome Drugs Market Size (2015-2020)
12.2 Dry Eye Syndrome Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
12.4 Central & South America Dry Eye Syndrome Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview and Its Total Revenue
  13.1.3 Allergan Dry Eye Syndrome Drugs Introduction
  13.1.4 Allergan Revenue in Dry Eye Syndrome Drugs Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Dry Eye Syndrome Drugs Introduction
  13.2.4 Novartis Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Santen
  13.3.1 Santen Company Details
  13.3.2 Santen Business Overview and Its Total Revenue
  13.3.3 Santen Dry Eye Syndrome Drugs Introduction
  13.3.4 Santen Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.3.5 Santen Recent Development
13.4 Takeda
  13.4.1 Takeda Company Details
  13.4.2 Takeda Business Overview and Its Total Revenue
  13.4.3 Takeda Dry Eye Syndrome Drugs Introduction
  13.4.4 Takeda Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.4.5 Takeda Recent Development
13.5 Otsuka
  13.5.1 Otsuka Company Details
  13.5.2 Otsuka Business Overview and Its Total Revenue
  13.5.3 Otsuka Dry Eye Syndrome Drugs Introduction
  13.5.4 Otsuka Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.5.5 Otsuka Recent Development
13.6 Eyegate Pharma
  13.6.1 Eyegate Pharma Company Details
  13.6.2 Eyegate Pharma Business Overview and Its Total Revenue
  13.6.3 Eyegate Pharma Dry Eye Syndrome Drugs Introduction
  13.6.4 Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.6.5 Eyegate Pharma Recent Development
13.7 Can-Fite BioPharma
  13.7.1 Can-Fite BioPharma Company Details
  13.7.2 Can-Fite BioPharma Business Overview and Its Total Revenue
  13.7.3 Can-Fite BioPharma Dry Eye Syndrome Drugs Introduction
  13.7.4 Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.7.5 Can-Fite BioPharma Recent Development
13.8 Bausch and Lomb
  13.8.1 Bausch and Lomb Company Details
  13.8.2 Bausch and Lomb Business Overview and Its Total Revenue
  13.8.3 Bausch and Lomb Dry Eye Syndrome Drugs Introduction
  13.8.4 Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.8.5 Bausch and Lomb Recent Development
13.9 Auven Therapeutics (Celtic)
  13.9.1 Auven Therapeutics (Celtic) Company Details
  13.9.2 Auven Therapeutics (Celtic) Business Overview and Its Total Revenue
  13.9.3 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Introduction
  13.9.4 Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.9.5 Auven Therapeutics (Celtic) Recent Development
13.10 Bridge Pharma
  13.10.1 Bridge Pharma Company Details
  13.10.2 Bridge Pharma Business Overview and Its Total Revenue
  13.10.3 Bridge Pharma Dry Eye Syndrome Drugs Introduction
  13.10.4 Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  13.10.5 Bridge Pharma Recent Development
13.11 Cellzome
  10.11.1 Cellzome Company Details
  10.11.2 Cellzome Business Overview and Its Total Revenue
  10.11.3 Cellzome Dry Eye Syndrome Drugs Introduction
  10.11.4 Cellzome Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
  10.11.5 Cellzome Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Dry Eye Syndrome Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Dry Eye Syndrome Drugs Revenue
Table 3. Ranking of Global Top Dry Eye Syndrome Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotic Drops
Table 6. Key Players of Hormone Drops
Table 7. Key Players of Artificial Tears
Table 8. COVID-19 Impact Global Market: (Four Dry Eye Syndrome Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Dry Eye Syndrome Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Dry Eye Syndrome Drugs Players to Combat Covid-19 Impact
Table 13. Global Dry Eye Syndrome Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Dry Eye Syndrome Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Dry Eye Syndrome Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Dry Eye Syndrome Drugs Market Share by Regions (2015-2020)
Table 17. Global Dry Eye Syndrome Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Dry Eye Syndrome Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Dry Eye Syndrome Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Dry Eye Syndrome Drugs Players
Table 24. Global Dry Eye Syndrome Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Dry Eye Syndrome Drugs Market Share by Players (2015-2020)
Table 26. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Syndrome Drugs as of 2019)
Table 27. Global Dry Eye Syndrome Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Dry Eye Syndrome Drugs Product Solution and Service
Table 30. Date of Enter into Dry Eye Syndrome Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Dry Eye Syndrome Drugs Market Size Share by Type (2015-2020)
Table 34. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Dry Eye Syndrome Drugs Market Size Share by Application (2015-2020)
Table 36. Global Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Dry Eye Syndrome Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Dry Eye Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Dry Eye Syndrome Drugs Market Share (2019-2020)
Table 40. North America Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 42. North America Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Dry Eye Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Dry Eye Syndrome Drugs Market Share (2019-2020)
Table 46. Europe Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 48. Europe Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Dry Eye Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Dry Eye Syndrome Drugs Market Share (2019-2020)
Table 52. China Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 54. China Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Dry Eye Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Dry Eye Syndrome Drugs Market Share (2019-2020)
Table 58. Japan Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 60. Japan Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Dry Eye Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Dry Eye Syndrome Drugs Market Share (2019-2020)
Table 64. Southeast Asia Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 66. Southeast Asia Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 68. India Key Players Dry Eye Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 69. India Key Players Dry Eye Syndrome Drugs Market Share (2019-2020)
Table 70. India Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. India Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 72. India Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. India Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Dry Eye Syndrome Drugs Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Dry Eye Syndrome Drugs Market Share (2019-2020)
Table 76. Central & South America Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 78. Central & South America Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 80. Allergan Company Details
Table 81. Allergan Business Overview
Table 82. Allergan Product
Table 83. Allergan Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 84. Allergan Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Santen Company Details
Table 91. Santen Business Overview
Table 92. Santen Product
Table 93. Santen Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 94. Santen Recent Development
Table 95. Takeda Company Details
Table 96. Takeda Business Overview
Table 97. Takeda Product
Table 98. Takeda Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 99. Takeda Recent Development
Table 100. Otsuka Company Details
Table 101. Otsuka Business Overview
Table 102. Otsuka Product
Table 103. Otsuka Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 104. Otsuka Recent Development
Table 105. Eyegate Pharma Company Details
Table 106. Eyegate Pharma Business Overview
Table 107. Eyegate Pharma Product
Table 108. Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 109. Eyegate Pharma Recent Development
Table 110. Can-Fite BioPharma Company Details
Table 111. Can-Fite BioPharma Business Overview
Table 112. Can-Fite BioPharma Product
Table 113. Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 114. Can-Fite BioPharma Recent Development
Table 115. Bausch and Lomb Business Overview
Table 116. Bausch and Lomb Product
Table 117. Bausch and Lomb Company Details
Table 118. Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 119. Bausch and Lomb Recent Development
Table 120. Auven Therapeutics (Celtic) Company Details
Table 121. Auven Therapeutics (Celtic) Business Overview
Table 122. Auven Therapeutics (Celtic) Product
Table 123. Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 124. Auven Therapeutics (Celtic) Recent Development
Table 125. Bridge Pharma Company Details
Table 126. Bridge Pharma Business Overview
Table 127. Bridge Pharma Product
Table 128. Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 129. Bridge Pharma Recent Development
Table 130. Cellzome Company Details
Table 131. Cellzome Business Overview
Table 132. Cellzome Product
Table 133. Cellzome Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (Million US$)
Table 134. Cellzome Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Dry Eye Syndrome Drugs Market Share by Type: 2020 VS 2026
Figure 2. Antibiotic Drops Features
Figure 3. Hormone Drops Features
Figure 4. Artificial Tears Features
Figure 5. Global Dry Eye Syndrome Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Household Use Case Studies
Figure 9. Dry Eye Syndrome Drugs Report Years Considered
Figure 10. Global Dry Eye Syndrome Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Dry Eye Syndrome Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Dry Eye Syndrome Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Dry Eye Syndrome Drugs Market Share by Players in 2019
Figure 15. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Syndrome Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Dry Eye Syndrome Drugs Revenue in 2019
Figure 17. North America Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Allergan Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novartis Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 28. Santen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Santen Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 30. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Takeda Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 32. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Otsuka Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 34. Eyegate Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Eyegate Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 36. Can-Fite BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Can-Fite BioPharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 38. Bausch and Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bausch and Lomb Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 40. Auven Therapeutics (Celtic) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Auven Therapeutics (Celtic) Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 42. Bridge Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Bridge Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 44. Cellzome Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Cellzome Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed